Hypericum for depression: An update of the clinical evidence

European Neuropsychopharmacology

Volumn 9, Issue 6, 1999, Pages 501-505

  Stevinson, C ^a   Ernst, E ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Clinical trials; Depression; Hypericum; Plant extract

Indexed keywords

ANTIDEPRESSANT AGENT; HYPERICUM PERFORATUM EXTRACT; PLACEBO; PSYCHOTONIN FORTE; UNCLASSIFIED DRUG;

AUTOMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; HAMILTON SCALE; HUMAN; HYPERICUM PERFORATUM; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RATING SCALE; REVIEW;

HYPERICUM PERFORATUM;

EID: 0033389387     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(99)00032-2     Document Type: Editorial

References (21)

1. DSM-IV Diagnostic and Statistical Manual of Mental Disorders. fourth ed. 1994;APA Press, Washington DC.
2. Bernhardt M., Liske E. Antidepressive Therapie mit Johanniskraut-Extrakt unter besonderer Berücksichtigung von zwei unterschiedlichen Dosierungsschemata. Jatros Neurol. 12:(9):1996;43-48.
3. Bhattacharya S.K., Chakrabarti A., Chatterjee S.S. Activity profiles of two hyperforin-containing hypericum extracts in behavioural models. Pharmocopsychiatry. 31:(Suppl):1998;22-29.
4. Cott J.M., Fugh-Berman A. Is St. John's wort (Hypericum perforatum) an effective antidepressant? J. Nerv. Ment. Dis. 168:(8):1998;500-501.
5. De Smet P.A.G.M., Nolen W.A. St. John's wort as an antidepressant. Br. Med. J. 313:1996;241-242.
6. Ernst E., Rand J., Barnes J., Stevinson C. Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L). Eur. J. Clin. Pharmacol. 54:1998;589-594.
7. Hänsgen K., Vesper J. Antidepressive Wirksamkeit eines hochdosierten Hypericum-Extraktes. Münch. Med. Wochenschr. 138:(3):1996;35-39.
8. Hänsgen K., Vesper J., Ploch M. Multicenter double-blind study examining the antidepressant effectiveness of the hypericum extract LI 160. J. Geriatr. Psychiatry Neurol. 7:(Suppl 1):1994;15-18.
9. Holden C. NIH to explore St. John's wort. Science. 278:1998;391.
10. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., McQuay H.J. Assessing the quality of reports of randomised clinical trials: Is blinding necessary? Control. Clin. Trials. 17:1996;1-12.
11. Laakmann G., Schule C., Baghai T., Kieser M. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmocopsychiatry. 31:(Suppl):1998;54-59.
12. Linde K., Ramirez G., Mulrow C.D., Pauls A., Weidenhammer W., Melchart D. St. John's wort for depression - an overview and meta-analysis of randomised clinical trials. Br. Med. J. 313:1996;253-258.
13. Müller W.E., Rolli M., Schäfer C., Hafner U. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry. 30:(Suppl):1997;102-107.
14. Müller W.E., Singer A., Wonnemann M., Hafner U., Rolli M., Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry. 31:(Suppl):1998;16-21.
15. Paykel E.S., Priest R.G. Recognition and management of depression in general practice: consensus statement. Br. Med. J. 305:1992;1198-1202.
16. Schrader E., Meier B., Brattström A. Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomised, placebo-controlled, multicentre study. Hum. Psychopharmacol. 13:1998;163-169.
17. Stevinson C., Ernst E. Safety of hypericum in patients with depression: a comparison with conventional antidepressants. CNS Drugs. 11:(2):1999;125-132.
18. Vorbach E.U., Arnoldt K.H., Hubner W.D. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry. 30:(Suppl):1997;81-85.
19. Wheatley D. LI 160, an extract of St. John's wort versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6 week clinical trial. Pharmacopsychiatry. 30:(Suppl):1997;77-80.
20. Witte B., Harrer G., Kaptan H., Podzuweit H., Schmidt U. Behandlung depressiver Verstimmungen mit einem hochkonzentrierten Hypericumpräparat. Fortschr. Med. 113:(28):1996;404-408.
21. The ICD-10 Classification of Mental and Behavioral Disorders. 1992;World Health Organisation, Geneva.